Members of the Hsp90 and Hsp70 family could serve as predictors for worse prognosis in cancer patients, since overexpression of HSP90AA1 and HSPA4, respectively, was shown to be associated with worse overall survival in different types of cancers (Figure 4). Here, HSPA4 is linked to cancer.